Most Recent
‘No sex’ and other rules make Uber an employer, court told
Uber drivers seeking to challenge their classification as independent contractors have argued the rideshare giant had “highly prescriptive” rules on how to behave towards customers, including 'no touching' and 'no sex' rules. 
High Court revives Sydney light rail class action against Transport for NSW
The High Court has revived a class action by small business owners over the interference caused by the construction of the Sydney light rail network.
Construction PRO
Sydney light rail class action revived by High Court
The High Court has revived a class action by small business owners over the interference caused by the construction of the Sydney light rail network.
Ex-Deloitte partner replaced for aspects of Mosaic liquidation
Special purpose liquidators have been appointed to failed clothing retailer Mosaic Brands, after a judge found a reasonable apprehension of bias arising from liquidator Vaughan Strawbridge's former link to Deloitte.
Takeovers Panel says Cosette can’t shutter Mayne’s Adelaide drug plant
The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.
Mayne wins extension of FIRB deadline for Cosette takeover
The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.
Mayne, Cosette row to be decided on merits after panel resets merger clock
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
Mayne wins breathing room in fight to get Cosette merger over the line
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
Cosette appeals loss over exit from $672M Mayne Pharma merger
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.
Mayne Pharma wins suit over Cosette’s termination of $672M takeover
Mayne Pharma has won a dispute with US drug maker Cosette over the termination of a $672 million merger agreement, with a judge finding Mayne did not breach its continuous disclosure obligations by failing to disclose a letter from the US FDA sooner.